Рет қаралды 720
Tom Harrison is Professor of Infectious Diseases and Medicine, Deputy Director of the Institute for Infection and Immunity, and Lead for the Centre of Global Health. He is also Honorary Consultant at St Georges University Hospitals NHS Foundation Trust and a member of the MRC Centre for Medical Mycology, based at the University of Exeter.
Here he talks about the outcomes of the ACTA and Ambition trials, that have both changed the treatment regimen for cryptococcal meningitis.